Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-168 Cr₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr

What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?

The latest Cash Flow from Financing Activities ratio of AJANTA PHARMA is ₹-168 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-168 Cr
Mar2025₹-733 Cr
Mar2024₹-1,051 Cr
Mar2023₹-108 Cr
Mar2022₹-460 Cr

How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-168 Cr
Negative
Mar2025 ₹-733 Cr
Negative
Mar2024 ₹-1,051 Cr
Negative
Mar2023 ₹-108 Cr
Negative
Mar2022 ₹-460 Cr -

Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹43,813.1 Cr -1.1% -0.3% 40.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,180.0 Cr 1.6% -1% 22.2% Stock Analytics
DIVIS LABORATORIES ₹243,302.0 Cr 1.7% 10.1% 49.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,623.0 Cr 1.5% -1.2% 38.2% Stock Analytics
CIPLA ₹114,554.0 Cr 0.7% -3.5% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,741.0 Cr -1.3% 0.1% -7.8% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1.1%

-0.3%

40.6%

SENSEX

-0.9%

-1.5%

-5.8%


You may also like the below Video Courses